Insiders · VIR

Jay Parrish

Officer at Vir Biotechnology, Inc. (VIR)

Jay Parrish has filed 4 insider reports with the SEC since February 2021, as officer at Vir Biotechnology, Inc. (VIR). Jay Parrish made no open-market purchases or sales in the last 12 months. In the latest filing, on April 5, 2021, Jay Parrish sold 6,944 shares of Vir Biotechnology, Inc. (VIR) for $357K at an average of $51.40.

Filings
4
Companies
1
Bought on market
None
Sold on market
$1.28M

Companies where Jay Parrish is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Vir Biotechnology, Inc. logo
VIR
Vir Biotechnology, Inc.
Officer9,260$1.28M$9.15Apr 5, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jay Parrish with

Other insiders at the same companies

Questions about Jay Parrish

What is Jay Parrish's role at Vir Biotechnology, Inc.?
Jay Parrish reports to the SEC as officer at Vir Biotechnology, Inc. (VIR), according to the latest filing on April 5, 2021.
How many shares does Jay Parrish own?
After the latest filing that states it, Jay Parrish directly owned 9,260 shares of Vir Biotechnology, Inc. (VIR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jay Parrish bought or sold stock recently?
The most recent open-market sale was on April 1, 2021: sold 6,944 shares of Vir Biotechnology, Inc. (VIR) for $357K at an average of $51.40.
How do I get alerts when Jay Parrish files?
Follow Jay Parrish on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jay Parrish (SEC CIK 0001786372). Totals count each trade once, skipping amendments whose original is on file, from Feb 2, 2021 on. View on SEC EDGAR